Over 80% of participants on the 12mg dose lost at least 15% of their body weight over 48 weeks
Get Your Product: Once approved, your product is shipped directly to your door in 57 days
That clinical pattern is now backed by data
These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication
4 If these indications continue to broaden and adoption scales accordingly, the cumulative impact on public health could be profound
There are no published guidelines regarding the optimal management of pasireotide-induced hyperglycemia in patients with acromegaly 22 , but the most currently recommended treatment is metformin, followed by dipeptidyl peptidase-4 (DPP-4) inhibitors, GLP-1 analogs, and then insulin 22,23,24